Consolidated Statement Of Comprehensive Income

Solasia Pharma K.K. - Filing #7272454

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
JPY
-1,941,000,000 JPY
JPY
JPY
-1,941,000,000 JPY
JPY
JPY
JPY
JPY
-1,112,000,000 JPY
JPY
JPY
JPY
-1,112,000,000 JPY
JPY
JPY
Other comprehensive income
Items that may be reclassified to profit or loss
Exchange differences on translation of foreign operations
7,000,000 JPY
9,000,000 JPY
Total of items that may be reclassified to profit or loss
7,000,000 JPY
9,000,000 JPY
Other comprehensive income
JPY
7,000,000 JPY
7,000,000 JPY
7,000,000 JPY
JPY
JPY
JPY
JPY
9,000,000 JPY
9,000,000 JPY
JPY
9,000,000 JPY
JPY
JPY
JPY
JPY
Comprehensive income
JPY
-1,933,000,000 JPY
7,000,000 JPY
7,000,000 JPY
-1,941,000,000 JPY
JPY
JPY
JPY
9,000,000 JPY
-1,103,000,000 JPY
JPY
9,000,000 JPY
JPY
-1,112,000,000 JPY
JPY
JPY
Comprehensive income attributable to
Owners of parent
-1,933,000,000 JPY
-1,103,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.